Insulin Aspart Injection Shortage

• • Fiasp Flextouch subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count, NDC 00169-3204-15
  • Fiasp Penfill subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count, NDC 00169-3205-15

• • Novo Nordisk did not provide a reason for the shortage. The company did not provide availability information on Relion products.

• • Fiasp subcutaneous injection, Novo Nordisk, 100 units/mL, 10 mL multiple dose vial, 1 count, NDC 00169-3201-11
  • Insulin Aspart Flexpen subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count, NDC 73070-0103-15
  • Insulin Aspart Penfill subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count, NDC 73070-0102-15
  • Novolog subcutaneous injection, Novo Nordisk, 100 units/mL, 10 mL multiple dose vial, 1 count, NDC 00169-7501-11
  • Novolog Flexpen subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count, NDC 00169-6339-10
  • Novolog Penfill subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count, NDC 00169-3303-12
  • Insulin Aspart subcutaneous injection, Novo Nordisk, 100 units/mL, 10 mL multiple dose vial, 1 count, NDC 73070-0100-11

Estimated Resupply Dates

• • Novo Nordisk has Fiasp Flextouch 3 mL pens on allocation through February 2025. Fiasp 3 mL Penfills are on back order and the company estimates a release date of early- to mid-February 2025.